NCT01419405View on ClinicalTrials.gov

Pregabalin and Remifentanil - Analgesia and Ventilation

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Pain
Interventions
DRUG

Pregabalin

hard capsule, 150 mg, 2 times, 2 days

DRUG

Remifentanil

50-90 min: TCI 0.6 ng/mL, 100-140 min: 1.2 ng/mL, 150-190 min: TCI 2.4 ng/mL

DRUG

sugar pill, saline infusion

hard capsule, 150 mg, 2 times, 2 days, saline infusion

Trial Locations (1)

0424

Oslo Universitetssykehus, Rikshospitalet, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT01419405 - Pregabalin and Remifentanil - Analgesia and Ventilation | Biotech Hunter | Biotech Hunter